Steward Partners Investment Advisory, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,000 shares of AMLX stock, worth $12,660. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,000
Previous 2,000
-0.0%
Holding current value
$12,660
Previous $5,000
40.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AMLX
# of Institutions
140Shares Held
46.4MCall Options Held
226KPut Options Held
909K-
Vanguard Group Inc Valley Forge, PA4.22MShares$26.7 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT3.34MShares$21.1 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.9 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.61MShares$16.5 Million0.0% of portfolio
-
Abrdn PLC1.97MShares$12.5 Million0.01% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $371M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...